Poated by Gary Storck
Thursday, Jan. 15, 2015
This letter did not publish itself. I called the editor and asked if it would be published. He stated that the Wisconsin Newspaper Association said that the grant funds could be used to target other drugs and so my contention was wrong although backed by news reports, the resolution text and the sponsors of the resolution. I later received an email stating it would be published.
By Steve Elliott
Two Democratic lawmakers have filed bills that would allow the use of medical marijuana in Indiana, but neither measure is likely to make any progress in the Republican-controlled Legislature, according to observers.
Sen. Karen Tallian (D-Portage) and Rep. Sue Errington (D-Muncie) are sponsoring bills in the Indiana Senate and House, respectively, that would allow state residents to use cannabis for medicinal purposes with a doctor's authorization, reports the Associated Press.
Errington's House bill would allow patients with conditions including cancer, glaucoma, AIDS, hepatitis C, Crohn's disease or Alzheimer's disease to use marijuana for treatment.
Unfortunately, the bill has been assigned to the House Rules and Legislative Procedures Committee, where it's unlikely to get a hearing, according to Errington.
"Bills that go there usually don't come back out," Errington told The Star Press. "I would like it to at least get a hearing, so people could come and tell their stories -- patients and physicians and others."
According to Errington, she's heard from constituents who are suffering from chronic pain and seizures, who would like to use medical marijuana to ease their suffering.
Stevia Corp., an international farm management company and healthcare company, has announced the filing of a second important provisional patent application with the United States Patent and Trademark Office for pain treatment using a combination of ibuprofen and cannabidiol (CBD).
The provisional patent application closely follows the company's previously announced first provisional patent application for pain management using acetaminophen and CBD. As in the previous application, this patent includes multiple claims including, but not limited to, combinations of cannabinoids including CBD and ibuprofen for the treatment of pain.
The provisional patent application, a legal document which establishes an early priority date for the benefit of claiming "first to file" status against other companies or individuals, "was filed with the assistance of an intellectual property attorney with extensive experience in the healthcare industry," according to a prepared statement from Stevia Corp.
CBD is a cannabinoid present in most varieties of the cannabis sativa and cannabis indica plants. Unlike THC and some of the other molecules found in cannabis, CBD is non-psychoactive.
CBD is also extremely well tolerated at high doses with little or no side effects; it is essentially non-toxic. It catapulted to national prominence after being an important part of Dr. Sanjay Gupta's 2013 CNN documentary, "Weed."
3rd Annual Conference in Washington DC, March 27-31
Medical marijuana advocacy group Americans for Safe Access (ASA) formally announced its third annual Unity Conference, "Wellness is Winning: Advancing Evidence Based Medical Cannabis Policy," by running an ad in USA Today.
The conference, which is being held in Washington, D.C. on March 27-31, 2015, will highlight medical and legal experts, policymakers, and a wide array of workshops and panels focusing on scientific research, strategic planning, and skills building. On Tuesday, March 31st, ASA will host a press conference at 11am, followed by Congressional lobbying visits by hundreds of patient advocates.
What: National Unity Conference: "Wellness is Winning: Advancing Evidence Based Medical Cannabis Policy"
When: March 27-31, 2015, including a press conference at 11 am on March 31
Where: Loews Madison Hotel, 1177 15th Street NW, Washington, DC 20005
The quarter-page USA Today ad, which ran all last week in the newspaper's NFL Super Bowl Preview publication, appeared on news stands across the country. This week, a digital version of the ad is running online for millions of Internet viewers.
Sponsors of the ad include the American Herbal Products Association, Cannabis Training Institute, Patient Focused Certification, and OrganiCann.
Backers of a new initiative to strengthen Washington state's medical marijuana law are now gathering signatures.
"Initiative Measure No. 1372, filed January 6, 2015, will protect and strengthen the medical cannabis law, RCW 69.51A, by offering compassion, clarity and consistency," said Kirk Ludden of Cannabis Patient Protection Washington (CPPWA) on Wednesday.
I-1372 would make the following changes, according to Ludden:
• Bringing Washington state law into compliance with stated federal policy
• Allowing business owners to obtain licenses for producing, processing or dispensing cannabis in a commercial manner. Using the language from ESSB 5073, specifying cannabis for medical use licensing, allowing producers and processors to deliver cannabis to any cannabis for medical use licensee, and allowing the botanical herb tax exemption on cannabis for medical use.
• Creating and empowering the cannabis for medical use board, made up of the state and the community, to govern all aspects of the market. Through licensing and regulation fees, revenue is generated for the board to regulate the not-for-profit cannabis for medical use market while remaining revenue neutral.
• Maintaining small, private residential gardens and patient cooperatives that do not violate the spirit or intent of law. As well as protecting existing cannabis farmer's markets serving qualifying patients.
By Steve Elliott
State Sen. David Haley (D-Kansas City) and state Rep. Gail Finney (D-Wichita) have once again introduced medical marijuana bills in the Kansas Legislature, as they've done every year since 2009.
None of the measures has ever gone beyond informational hearings, in which no action can be taken, but Sen. Haley thinks that might change this year, reports Amy Himmelberg of the Associated Press.
"I think the ice is beginning to thaw regarding the reasonableness of the issue among the leadership of the Legislature," Haley said.
Rep. Finney -- who has undergone chemotherapy for lupus -- thinks the bill will at least get a hearing after being ignored by Republican legislators for years. "Passing, I don't know about that," she added.
Rep. Dan Hawkins (R-Wichita), chairman of the House Health and Human Services Committee, said he's waiting to see what the Senate does with medical marijuana. "Nobody's come and really pushed it," Hawkins claimed, adding that he's heard "very little" from constituents about it. If you'd like to change that, you can click here and let Rep. Hawkins hear from the people he's supposed to be representing.